BTMD.NASDAQBiote CORP

SCHEDULE 13D: Significant Investor Richard Barrera Joins biote Corp. Board, Disclosing 14% Stake

Sentiment:

Beneficial Ownership Disclosure


A group of investors led by Richard Barrera, including Guines LLC and Roystone Management Holdings LLC, has disclosed a 14.0% beneficial ownership stake in biote Corp. following Barrera's appointment to the company's board of directors.

Summary

  • The Schedule 13D filing was made jointly by Guines LLC (the "Fund"), Roystone Management Holdings LLC ("Roystone"), RB Management GP LLC (the "Manager"), and Richard Barrera (collectively, the "Reporting Persons").
  • The Reporting Persons collectively beneficially own 4,622,748 shares of biote Corp.'s Class A common stock, representing 14.0% of the outstanding shares.
  • The outstanding common stock figure of 33,073,277 shares is based on the Issuer's 10-Q filed on May 9, 2025.
  • The primary purpose of the filing is to report that Richard Barrera, managing member of RB Management GP LLC, was appointed to biote Corp.'s board of directors on June 5, 2025.
  • The funds used for the purchase of the common stock came from the working capital of Guines LLC, with no borrowed funds used specifically for the purchase, other than for ordinary course working capital.
  • Recent acquisitions of Class A common stock by the Reporting Persons include: 1,000 shares on April 16, 2025, at a weighted average price of $3.2915; 6,874 shares on April 17, 2025, at $3.2899; 8,801 shares on April 21, 2025, at $3.2703; 1,933 shares on April 30, 2025, at $3.296; 436,037 shares on May 6, 2025, at $3.2618; and 11,677 shares on May 7, 2025, at $3.3491.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. A significant investor taking a board seat suggests a deeper commitment and potential for strategic input, which can be viewed favorably by the market. The investment purpose is stated as long-term, and no negative intentions or financial distress are indicated.

Positives

  • The appointment of Richard Barrera, a representative of a significant investor group, to the board of directors could enhance shareholder representation and strategic oversight.
  • The Reporting Persons' original acquisition of common stock was for investment purposes, suggesting a long-term interest in the company's performance.
  • The investment was funded through working capital, indicating financial stability of the investing entities.

Risks

  • The Reporting Persons reserve the right to effect future changes or transactions in the number of shares they beneficially own, which could include open-market or privately negotiated transactions, potentially impacting share price volatility.
  • The Reporting Persons may communicate with the Issuer's management, board, and other shareholders, which could lead to strategic shifts or disagreements.

Future Outlook

The Reporting Persons originally acquired the common stock for investment purposes and reserve the right to effect one or more changes or transactions in the number of shares they may be deemed to beneficially own in open-market or privately negotiated transactions, subject to market conditions and applicable securities laws. They may also communicate with the Issuer's management, board, and other shareholders from time to time.

Industry Context

This filing indicates a significant investor's increased engagement with biote Corp., a company likely operating in the health and wellness sector. Such a move by a substantial shareholder, particularly with a board appointment, often signals a belief in the company's long-term value or a desire to influence its strategic direction, which can be a positive signal within the industry.

Comparison to Industry Standards

  • NA

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Board of Directors MemberNARichard BarreraJune 5, 2025Appointment to the Issuer's board of directors.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board Composition ChangeRichard Barrera, managing member of RB Management GP LLC and a representative of a significant shareholder group, was appointed to the Issuer's board of directors.June 5, 2025This change introduces a new voice and perspective from a major investor onto the board, potentially influencing strategic decisions and corporate oversight. It enhances shareholder representation at the board level.

Related Party Transactions

  • The filing itself is a joint agreement among the Reporting Persons (Guines LLC, Roystone Management Holdings LLC, RB Management GP LLC, and Richard Barrera) to file this Schedule 13D, indicating a coordinated effort among related entities/individuals regarding their investment in biote Corp.

Stakeholder Impact

  • Shareholders: The appointment of a representative from a significant investor group to the board could be seen as a positive for shareholder advocacy and strategic direction.
  • Management: The presence of a new board member representing a large shareholder may lead to increased scrutiny or collaboration on strategic initiatives.

Next Steps

  • The Reporting Persons may engage in further transactions involving biote Corp. common stock.
  • The Reporting Persons may communicate with biote Corp.'s management, board, and other shareholders.

Key Dates

DateDescription
April 16, 2025Acquisition of 1,000 Class A common shares at $3.2915.
April 17, 2025Acquisition of 6,874 Class A common shares at $3.2899.
April 21, 2025Acquisition of 8,801 Class A common shares at $3.2703.
April 30, 2025Acquisition of 1,933 Class A common shares at $3.296.
May 6, 2025Acquisition of 436,037 Class A common shares at $3.2618.
May 7, 2025Acquisition of 11,677 Class A common shares at $3.3491.
May 9, 2025Date of Issuer's 10-Q filing reporting 33,073,277 Common Stock outstanding.
June 5, 2025Date of event requiring filing: Richard Barrera's appointment to the Issuer's board of directors.
June 9, 2025Date of Issuer's Current Report on Form 8-K filed with the SEC regarding the board appointment.
June 12, 2025Date of Schedule 13D filing.

Recommendation

hold

Keywords

biote Corp, Schedule 13D, beneficial ownership, Richard Barrera, board appointment, investment adviser, common stock, shareholder activism, corporate governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.